Sartorius Stedim Biotech SA DIM
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- €218.00
- Day Range
- €216.60–218.20
- 52-Week Range
- €152.00–224.20
- Bid/Ask
- €0.00 / €0.00
- Shares Outstanding
- 97.29M
- Market Cap
- €21.21B
- Volume/Avg
- — / 17
Key Statistics
- Price/Earnings (Normalized)
- 54.59
- Price/Sales
- 7.05
- Dividend Yield (Trailing)
- 0.32%
- Dividend Yield (Forward)
- 0.32%
- Dividend Payment Schedule
- Apr
- Total Yield
- 0.32%
Company Profile
Sartorius Stedim Biotech is a leading provider of bioprocessing solutions. It sells equipment and consumables for fermentation, filtration, fluid management, purification, and cell culture media for manufacturing biologic drugs and has a focus on single-use technology. It is a subsidiary of Sartorius AG, which has 71.5% ownership and 83% voting control. The business is geographically diverse, with 35% of sales from the Americas, 42% from Europe, the Middle East, and Africa, 15% from Asia excluding China, and 8% from China.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Mid Core
- Total Number of Employees
- 10,477
- Website
- https://www.sartorius.com
Competitors
Valuation
|
Metric
|
DIM
|
MRK
|
A
|
|---|---|---|---|
Price/Earnings (Normalized) | 54.59 | 17.06 | 28.32 |
Price/Book Value | 5.01 | 1.98 | 6.57 |
Price/Sales | 7.05 | 2.83 | 6.60 |
Price/Cash Flow | 34.86 | 13.15 | 25.65 |
Price/Earnings
DIM
MRK
A
Financial Strength
|
Metric
|
DIM
|
MRK
|
A
|
|---|---|---|---|
Quick Ratio | 0.48 | 0.99 | 1.41 |
Current Ratio | 1.16 | 1.69 | 2.05 |
Interest Coverage | 4.24 | 7.22 | 16.08 |
Quick Ratio
DIM
MRK
A
Profitability
|
Metric
|
DIM
|
MRK
|
A
|
|---|---|---|---|
Return on Assets (Normalized) | 5.40% | 4.75% | 13.27% |
Return on Equity (Normalized) | 10.62% | 8.32% | 24.92% |
Return on Invested Capital (Normalized) | 7.74% | 6.65% | 16.95% |
Return on Assets
DIM
MRK
A
Medical Instruments & Supplies Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Intuitive Surgical Inc
ISRG
| LOCK|>TlJQhsb | LOCK|?kL | $148B | |||
| Becton Dickinson & Co
BDX
| LOCK|XL | LOCK|%bV< | $51B | |||
| ResMed Inc
RMD
| LOCK|kH>zbW$D | LOCK|Pb^nJ | $33B | |||
| Medline Inc Ordinary Shares - Class A
MDLN
| LOCK|MQQXHG | LOCK|h^LZ | $32B | |||
| Alcon Inc
ALC
| LOCK|LrTz!^ | LOCK|s@#>@ | $31B | |||
| West Pharmaceutical Services Inc
WST
| LOCK|n<bJ?PF | LOCK|fyy | $26B | |||
| Solventum Corp
SOLV
| LOCK|^wHs#< | LOCK|$@ | $15B | |||
| Baxter International Inc
BAX
| LOCK|FF | LOCK|^r!@ | $13B | |||
| Repligen Corp
RGEN
| LOCK|#@>@TQg | LOCK|?><S | $11B | |||
| The Cooper Companies Inc
COO
| LOCK|nXs#&bm | LOCK|Fn>l | $10B |
United States